39 results on '"Cortelezzi, Agostino"'
Search Results
2. Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly
3. Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
4. LDH as Predictive Parameter in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12
5. Allogeneic stem cell transplantation in advanced stage mycosis fungoides and Sézary syndrome: 2018 update of the Milan experience
6. Heterogeneity among splanchnic vein thrombosis associated with myeloproliferative neoplasms
7. Mutations of BRAF and BIRC3 Identify a Subgroup of Chronic Lymphocytic Leukemia with Very Poor Prognosis upon FCR Treatment
8. In Adult Acute Lymphoblastic Leukemia End of Induction MRD Correlates Strongly with Subsequent Key Timepoints and Predicts Long Term Outcome
9. Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial
10. An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature review
11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) role in hematopoiesis and in hematologic diseases: A critical review
12. Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome
13. Feasibility of Allogeneic Stem Cell Transplantation After Azacitidine in Patients with High Risk Myelodysplastic Syndromes or Low-Blast Count Acute Myeloid Leukemias: the Experience of the BMT-AZA Multicenter Prospective Study
14. Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review
15. Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms
16. Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments
17. Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study
18. Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment
19. Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis
20. PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis
21. Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile
22. Comorbidities and polypharmacy impact on complete cytogenetic response in chronic myeloid leukaemia elderly patients
23. Increased prevalence of autoimmune phenomena in myelofibrosis: Relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns
24. Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome
25. The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis
26. A new variant of phosphoglycerate kinase deficiency (p.I371K) with multiple tissue involvement: Molecular and functional characterization
27. 5.10 Combination of Bendamustine and Ofatumumab (Bendofa) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia: A Preliminary Report
28. 1.2 Relevance of Stereotyped B-Cell Receptors in the Context of the Molecular, Cytogenetic and Clinical Features of CLL
29. 2.4 Expression of TLRs in B-CLL: Relationship with Disease Activity
30. 3.20 Stereotyped B-Cell Receptor is Associated with Immune Thrombocytopenia in CLL
31. Oxidative stress is increased in primary and post−polycythemia vera myelofibrosis
32. Clinical categories identified by a new prognostic index reflect biological characteristics of patients in early chronic lymphocytic leukemia: The Gruppo Italiano Studio Linfomi (GISL) experience
33. Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease
34. FISH characterization of t(8;12)(q12;p13) observed as the sole karyotypic anomaly in a myelodysplastic syndrome patient
35. Efficacy of N-acetylcysteine and all-trans retinoic acid in restoring in vitro effective hemopoiesis in myelodysplastic syndromes
36. Low plasma stem cell factor levels correlate with in vitro leukemic growth in myelodysplastic syndromes
37. Interferon therapy during the plateau phase of multiple myeloma: An update of the Swedish study
38. Incidence of jaw lesions in 193 patients with multiple myeloma
39. Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.